There have been fundamental changes in the approach to breast cancer management over the last century but the primary objective of achieving oncological safety remains unchanged. This evolution is highlighted with a summary of the key evidences in support of the oncological safety of breast conserving surgery (BCS) in early breast cancer (EBC) management. We will also discuss the increasingly pivotal role that neoadjuvant chemotherapy (NACT) may play, in the local treatment of EBC and locally advanced breast cancer (LABC) and the long-term surgical and oncological outcomes
Neoadjuvant chemotherapy (NAC) increases rates of successful breast conserving surgery (BCS) in pati...
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surger...
Background: Treatment with neoadjuvant chemotherapy (NAC) has made it possible for some women to be ...
Neoadjuvant chemotherapy (NACT) in locally advanced breast tumors may allow an adequate control of t...
BACKGROUND: Breast-conserving surgery (BCS) in patients with large tumors shrunk by neoadjuvant che...
The definition of locally advanced breast cancer mainly describes the clinically stage III disease. ...
The surgical treatment of breast cancer has undergone continuous and profound changes over the last ...
The main rationale for neoadjuvant therapy for breast cancer is to provide effective systemic treatm...
The main rationale for neoadjuvant therapy for breast cancer is to provide effective systemic treatm...
Neo-adjuvant chemotherapy (NAC) for early breast cancer (sometimes referred to as primary or preoper...
AbstractIntroductionIn absence of randomized evidence to support safety of conservative surgery (BCT...
Chemotherapy has played a significant role in breast cancer therapy and dramatically improved the ou...
Locally advanced breast cancer (LABC) represents a worldwide major challenge, with a reported incide...
The current concept of breast cancer treatment arises from Fisher's theory that operable breast canc...
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surger...
Neoadjuvant chemotherapy (NAC) increases rates of successful breast conserving surgery (BCS) in pati...
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surger...
Background: Treatment with neoadjuvant chemotherapy (NAC) has made it possible for some women to be ...
Neoadjuvant chemotherapy (NACT) in locally advanced breast tumors may allow an adequate control of t...
BACKGROUND: Breast-conserving surgery (BCS) in patients with large tumors shrunk by neoadjuvant che...
The definition of locally advanced breast cancer mainly describes the clinically stage III disease. ...
The surgical treatment of breast cancer has undergone continuous and profound changes over the last ...
The main rationale for neoadjuvant therapy for breast cancer is to provide effective systemic treatm...
The main rationale for neoadjuvant therapy for breast cancer is to provide effective systemic treatm...
Neo-adjuvant chemotherapy (NAC) for early breast cancer (sometimes referred to as primary or preoper...
AbstractIntroductionIn absence of randomized evidence to support safety of conservative surgery (BCT...
Chemotherapy has played a significant role in breast cancer therapy and dramatically improved the ou...
Locally advanced breast cancer (LABC) represents a worldwide major challenge, with a reported incide...
The current concept of breast cancer treatment arises from Fisher's theory that operable breast canc...
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surger...
Neoadjuvant chemotherapy (NAC) increases rates of successful breast conserving surgery (BCS) in pati...
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surger...
Background: Treatment with neoadjuvant chemotherapy (NAC) has made it possible for some women to be ...